Provided by Tiger Trade Technology Pte. Ltd.

Cytosorbents

0.3553
-0.0149-4.02%
Post-market: 0.36050.0052+1.46%18:44 EDT
Volume:123.63K
Turnover:45.56K
Market Cap:22.31M
PE:-1.22
High:0.3900
Open:0.3700
Low:0.3500
Close:0.3702
52wk High:1.04
52wk Low:0.3000
Shares:62.80M
Float Shares:52.74M
Volume Ratio:0.72
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2901
EPS(LYR):-0.1317
ROE:-336.21%
ROA:-17.12%
PB:-29.71
PE(LYR):-2.70

Loading ...

CytoSorbents Releases Investor Presentation on Blood Purification Devices for ICU, Cardiac Surgery Use

Reuters
·
Aug 19

CytoSorbents Holds Annual Shareholder Meeting

Reuters
·
Aug 15

CytoSorbents Posts Investor Presentation Outlining Q2 Revenue, Cash Burn Progress Toward Breakeven

Reuters
·
Aug 12

Cytosorbents Advances Toward Operating Cash Flow Breakeven

TIPRANKS
·
Aug 08

Canada's Spectral Medical Q2 Revenue Falls on Lower Reagent Sales

Reuters
·
Aug 07

Cytosorbents Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

CytoSorbents Q2 FY26 Operating Loss Narrows 27% to $2.6 Million; Revenue Rises 0.2% to $9.6 Million

Reuters
·
Aug 07

CytoSorbents Q2 Adjusted Loss Narrows on Cost Controls

Reuters
·
Aug 07

CytoSorbents Q2 Revenue USD 9.633 Million

Reuters
·
Aug 07

Cytosorbents Q2 Gross Margin 73%

THOMSON REUTERS
·
Aug 07

CytoSorbents Q2 Adj. EPS $(0.07) Misses $(0.04) Estimate, Sales $9.633M Beat $9.346M Estimate

Benzinga Earnings
·
Aug 07

Cytosorbents Corp Expected to Post a Loss of 4 Cents a Share - Earnings Preview

Reuters
·
Aug 05

Cytosorbents Updates Financial Calendar with Q2 Results Release, Conference Call Scheduled

Reuters
·
Jul 20

Cytosorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights

THOMSON REUTERS
·
Jul 20

Cytosorbents Faces Nasdaq Compliance and Delisting Risk

TIPRANKS
·
Jul 07

Cytosorbents Gets NASDAQ Notice for Falling Below $35 Million Market Value Threshold

Reuters
·
Jul 07

Cytosorbents Posts Investor Presentation Outlining Blood Purification Products, Drugsorb-atr Regulatory Path

Reuters
·
Jun 25

Insider Spends US$105k Buying More Shares In Cytosorbents

Simply Wall St.
·
Jun 22

CytoSorbents CEO to present at Virtual Investor Conferences Life Sciences Forum

Reuters
·
Jun 18

CytoSorbents CFO Peter J. Mariani acquires 100,000 common shares worth $44,000

Reuters
·
Jun 16